Whiteley Corp and University of Newcastle join forces to develop advanced manufacturing capability for new human therapeutics plant at Tomago

Penelope Green
Updated April 14 2021 - 11:38pm, first published October 13 2020 - 5:30am
Cutting edge: Whiteley Corporation's Darran Leyden and Associate Professor James Welsh from the University of Newcastle. Picture: Marina Neil
Cutting edge: Whiteley Corporation's Darran Leyden and Associate Professor James Welsh from the University of Newcastle. Picture: Marina Neil

WHITELEY Corporation's $10 million-plus investment in a human therapeutics plant to be built near its Tomago base has been bolstered with a research collaboration with the University of Newcastle.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options
Penelope Green

Penelope Green

Journalist, Newcastle Herald

Business, news and feature reporter.

Get the latest Newcastle news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.